Compare Medpace Holdings Inc (MEDP) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Zillow Group Inc Class C — how do they compare? Medpace Holdings Inc trades at $534.05 (market cap $15.35B), while Zillow Group Inc Class C trades at $33.32 (market cap $7.75B). The key difference: Medpace Holdings Inc is the larger of the two by market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Zillow Group Inc Class C nearer its low. Which is the better fit depends on your goals.
| MEDP | Z | |
|---|---|---|
Market Cap | $15.35B | $7.75B |
Sector | Technology | Media |
52-Week High | $620.59 | $90.35 |
52-Week Low | $308.88 | $29.41 |
Enterprise Value | $14.82B | $7.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $534.49, down 0.6% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a 17.19% net income margin and 77.25% ROE, though valuations are elevated with a P/E of 33.83. Recent quarters have consistently beaten EPS estimates, and 2026 forecasts project revenue growth to $2.7B. News highlights focus on CRO demand shifts and a class action lawsuit filed in June 2026.
Outlook remains positive given earnings momentum and sector demand, but risks include legal overhangs and high valuation multiples. Analyst consensus is mixed with a $497 price target below current levels, suggesting cautious optimism amid near-term headwinds.
Zillow Group (Z) trades at $33.27, down 1.87% today, amid a bearish technical signal and negative cash flow trends. The company shows improving fundamentals with revenue growth from $2.2B in 2024 to $2.6B in 2025 and a return to profitability, though net margins remain thin at 0.89%. Recent earnings have been mixed, with a beat in Q1 2026 but a miss in Q4 2025. Analyst consensus is a Buy with a $57.67 price target, but sentiment is clouded by multiple class-action lawsuits alleging securities fraud.
The outlook is cautious due to legal overhangs and high valuation multiples, yet long-term growth in housing data services offers potential. Key risks include litigation outcomes, competitive pressures, and execution on profit expansion. Investors should weigh the high P/E of 135.72 against projected earnings improvements and monitor legal developments closely.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
